A review regarding the article 'Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure'
- PMID: 38821235
- DOI: 10.1016/j.cpcardiol.2024.102688
A review regarding the article 'Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure'
Abstract
Acute heart failure (AHF) is characterized by the emergence or intensification of symptoms and signs indicative of congestion or systemic hypoperfusion, stemming from an underlying structural or functional cardiac disorder. Intravenous loop diuretics play a pivotal role in achieving effective decongestion and ensuring clinical stability; the efficacy of these medications is crucial for determining the patient's hospital course and early outpatient progression. Individuals who exhibit a suboptimal response to diuretics or develop diuretic resistance (DR) are at an elevated risk for cardiovascular mortality and readmission due to AHF. However, there is a lack of standardized definition and diagnostic criteria for DR. Early identification of patients with DR is critical, as they may benefit from more aggressive decongestion strategies to mitigate this resistance. Natriuresis, the excretion of sodium in urine, serves as a direct measure of a diuretic's effectiveness. Low levels of natriuresis have been linked to poorer outcomes. Several studies have underscored the prognostic significance of natriuresis across various heart failure scenarios. However, the relationship between natriuresis and in-hospital DR has not been extensively studied. Observational research has indicated that inadequate natriuresis following the administration of loop diuretics correlates with a diminished diuretic response and an increased likelihood of mortality and heart failure rehospitalization. Further investigation is warranted to assess the predictive value of basal natriuresis concerning DR, in-hospital outcomes, and early outpatient cardiovascular events. This would help in identifying patients who are likely to respond poorly to diuretic therapy and may require alternative or more intensive treatment approaches.
Keywords: Acute heart failure; Basal natriuresis; Cardiovascular mortality; Diuretic resistance.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Diuretic Resistance in Heart Failure.Curr Heart Fail Rep. 2019 Apr;16(2):57-66. doi: 10.1007/s11897-019-0424-1. Curr Heart Fail Rep. 2019. PMID: 30762178 Free PMC article. Review.
-
Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure.Curr Probl Cardiol. 2024 Aug;49(8):102674. doi: 10.1016/j.cpcardiol.2024.102674. Epub 2024 May 23. Curr Probl Cardiol. 2024. PMID: 38795800 Review.
-
Prevalence and characteristics of upfront diuretic resistance in acute heart failure: The P-Value-AHF study.ESC Heart Fail. 2025 Feb;12(1):688-694. doi: 10.1002/ehf2.15069. Epub 2024 Sep 6. ESC Heart Fail. 2025. PMID: 39239801 Free PMC article. Clinical Trial.
-
Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.Eur J Heart Fail. 2019 Nov;21(11):1415-1422. doi: 10.1002/ejhf.1478. Epub 2019 May 9. Eur J Heart Fail. 2019. PMID: 31074184 Clinical Trial.
-
Natriuresis-guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial.Eur J Heart Fail. 2022 Feb;24(2):385-392. doi: 10.1002/ejhf.2385. Epub 2022 Jan 6. Eur J Heart Fail. 2022. PMID: 34791756 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical